Regeneron’s antibody cocktail REGN-EB3 (Inmazeb) first FDA-approved treatment for Ebola (Zaire Ebolavirus)
On Oct. 14, 2020, Regeneron announced that the FDA had approved Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) for the…
Veklury (remdesivir) made available directly from distributor
On Oct. 1, 2020, american hospitals began purchasing Veklury (remdesivir) directly from the drugï¾’s distributor. Veklury is an…
Oxford Immunotec announced FDA clearance of the T-SPOT.TB test for use in pediatrics over the age of two
On Sept. 29, 2020, Oxford Immunotec announced that it had received clearance from the FDA to amend the…
Study found that childrenï¾’s immune response protected against COVID-19
On Sept. 21, 2020, a study comparing the immune responses of adults and children with COVID-19 detected key…
Evidence suggested children could play a larger role in community spread of COVID-19
On Aug. 20, 2020, in the most comprehensive study of COVID-19 pediatric patients to date, Harvard Medical School…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Medical Device | Neurology | Therapeutics
The FDA permitted marketing of first game-based digital therapeutic to improve attention function in children with ADHD
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) permitted marketing of the first game-based digital…
Biotechnology | CDC | HIV | Life Science News | Therapeutics
The FDA approved drug to treat infants and children with HIV
On Jun. 12, 2020, the U.S. Food and Drug Administration (FDA) approved ViiV Healthcare’s Tivicay (dolutegravir) tablets and…
The FDA approved only drug in U.S. to treat severe malaria
On May 26, 2020, the FDA approved Amivas’ artesunate for injection to treat severe malaria in adult and…
The FDA approved only drug in the U.S. to treat severe malaria
On May 26, 2020, the FDA provided approval to Amivas for its artesunate for injection to treat severe…
The FDA issued an emergency use authorization (EUA) for the Philips Medizin Systeme Boeblingen
On Apr. 22, 2020, the FDA issued an emergency use authorization (EUA) for the Philips Medizin Systeme Boeblingen…
FDA approved first therapy for children with debilitating and disfiguring rare disease
On Apr. 10, 2020, the FDA approved AstraZeneca ‘s Koselugo (selumetinib) for treatment of pediatric patients, 2 years…
Philips ramped up production of critical health technology products in response to COVID-19 pandemic
On Mar. 22, 2020, Philips announced that Childrenï¾’s Hospital of Georgia has adopted Philipsï¾’ automated early detection and…
Dr. Claudia Kleinman, Dr. Nada Jabado, and Dr. Michael Taylor discovered that pediatric brain tumors derive from a genetic event early in cellular development
On Nov. 25, 2019, Dr. Claudia Kleinman, Dr. Nada Jabado, and Dr. Michael Taylor discovered that pediatric brain…
UPenn completed exclusive R&D alliance with Novartis
On Sept. 12, 2019, UPenn completed its exclusive, 7-year research and development alliance with Novartis, that spawned the…
Geneticist Dr. Judith G. Hall was awarded the Rimoin Lifetime Achievement Award
On Apr. 11, 2018, Dr. Judith G. Hall, professor emerita of pediatrics and medical genetics at the University…
MMK Foundation donated $1 million to Children’s Health, Southwestern Medical Center
On Feb. 28, 2018, The MMK Foundation, founded by Mark and Marcia King, pledged $1 million to be…
FDA approval brought first gene therapy to the U.S.
On Aug. 30, 2017, the U.S. Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) for certain pediatric and…
NIH selected OHSU Knight Cancer Institute to co-lead largest national database for pediatric cancer, rare disease research
On Aug. 15, 2017, the National Institutes of Health’s (NIH) Gabriella Miller Kids First Pediatric Research Program awarded…
NIH announced final rule requirements for submitting clinical trial results information
On Sept. 21, 2016, the National Institutes of Health (NIH) announced final rule requirements for submitting registration and…
UC Berkeley, UC San Francisco and Stanford partnered in $600 million Chan Zuckerberg science ‘Biohub’
On Sept. 21, 2016, the University of California, Berkeley, UC San Francisco and Stanford University joined forces in…
Juno Theraputics completed its IPO
On Dec. 23, 2014, Juno Therapeutics announced the closing of its initial public offering of 12.7 million shares…
The University of Minnesota received early fulfillment of transformational health gifts
On Mar. 25, 2014, the University of Minnesota Foundation announced that Caroline Amplatz had made early fulfillment of…
Juno Theraputics was founded
On Dec. 3, 2013, Juno Theraputics, a biotechnology company focused on bringing forward novel immunotherapies for cancer, was…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Neurology | Non-Profit Research | Therapeutics
A second $10 million gift from Jerre and Mary Joy Stead advances children’s medicine at the University of Iowa
On Oct. 24, 2013, the University of Iowa (IA) announced a second $10 million gift commitment from Jerre…
Meta Analysis Study Shows Impact of fluoride on neurological development in children
On Jul. 25, 2012, in a meta-analysis, researchers from the China Medical University in Shenyang and Harvard School…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics | Women's Health
The University of Minnesota Masonic Children’s Hospital opened a new, innovative building for mothers and children
On Apr. 30, 2011, The University of Minnesota Masonic Children’s Hospital opened a new, innovative building for mothers…
AGA Medical was acquired by St Jude Medical for $1.3 billion in cash
On Nov. 18, 2010, AGA Medical was acquired by St. Jude Medical for $1.3 billion in cash. The…
St. Jude Children’s Hospital launched the Pediatric Cancer Genome Project
On Jan. 25, 2010, St. Jude Children’s Research Hospital and Washington University School of Medicine launched a $65…
AGA Medical completed its IPO worth $1.3 billion
On Oct. 20, 2009, AGA Medical, based in Plymouth, designed and sold small devices that closed defects in…
Caroline Amplatz pledged $50 million for the university’s new children’s hospital
On Feb 10, 2009, Caroline Amplatz pledged $50-million to the Minnesota Medical Foundation, in Minneapolis, to support the…